Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Shanghai OPM Biosciences Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	296.78	242.69	294.27	212.68	124.97
Other Revenue	0.47	0.43	0.1	-	-
Revenue	297.24	243.12	294.37	212.68	124.97
Revenue Growth (YoY)	22.26%	-17.41%	38.41%	70.19%	113.55%
Cost of Revenue	142.34	101.53	107.25	86	68.01
Gross Profit	154.9	141.59	187.12	126.69	56.96
Selling, General & Admin	105.94	74.47	60	50.96	29.69
Research & Development	33.37	41.91	32.19	19.03	20.51
Other Operating Expenses	2.21	-0.23	1.17	0.78	0.17
Operating Expenses	148.44	122.57	98.11	71.09	50.47
Operating Income	6.46	19.02	89	55.6	6.49
Interest Expense	-3.12	-3.23	-4.98	-4.79	-2.45
Interest & Investment Income	31.14	36.3	17.98	9.07	3.56
Currency Exchange Gain (Loss)	2.4	0.87	2.24	-0.24	-0.53
Other Non Operating Income (Expenses)	-0.05	-0.09	-0.14	-0.07	-0.15
EBT Excluding Unusual Items	36.84	52.89	104.09	59.57	6.91
Gain (Loss) on Sale of Investments	4.63	1.53	1.67	-	-
Gain (Loss) on Sale of Assets	0.09	-0.02	0.29	-0.02	-
Asset Writedown	-7.51	-	-	-	-0
Other Unusual Items	2.38	7.26	13.38	8.61	4.77
Pretax Income	36.43	61.67	119.43	68.15	11.68
Income Tax Expense	16.19	8.41	14.06	7.76	-
Earnings From Continuing Operations	20.24	53.26	105.37	60.39	11.68
Minority Interest in Earnings	0.82	0.78	-	-	-
Net Income	21.05	54.04	105.37	60.39	11.68
Net Income to Common	21.05	54.04	105.37	60.39	11.68
Net Income Growth	-61.04%	-48.72%	74.47%	416.87%	-
Shares Outstanding (Basic)	111	115	101	86	86
Shares Outstanding (Diluted)	117	115	101	86	86
Shares Change (YoY)	1.72%	13.48%	17.43%	0.20%	-
EPS (Basic)	0.19	0.47	1.04	0.70	0.14
EPS (Diluted)	0.18	0.47	1.04	0.70	0.14
EPS Growth	-61.70%	-54.81%	48.57%	415.84%	-
Free Cash Flow	-51.61	-19.59	-35.34	8.64	-33.04
Free Cash Flow Per Share	-0.44	-0.17	-0.35	0.10	-0.38
Dividend Per Share	0.420	0.440	0.429	-	-
Dividend Growth	-4.47%	2.66%	-	-	-
Gross Margin	52.11%	58.24%	63.57%	59.56%	45.58%
Operating Margin	2.17%	7.82%	30.23%	26.14%	5.19%
Profit Margin	7.08%	22.23%	35.80%	28.40%	9.35%
Free Cash Flow Margin	-17.36%	-8.06%	-12.01%	4.06%	-26.44%
EBITDA	42.22	47.04	113.28	74.34	21.98
EBITDA Margin	14.21%	19.35%	38.48%	34.96%	17.58%
D&A For EBITDA	35.76	28.02	24.28	18.74	15.49
EBIT	6.46	19.02	89	55.6	6.49
EBIT Margin	2.17%	7.82%	30.23%	26.14%	5.19%
Effective Tax Rate	44.45%	13.63%	11.78%	11.39%	-
Revenue as Reported	297.24	243.12	294.37	212.68	124.97
Advertising Expenses	2.08	2.29	1.34	0.73	0.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.